PHR’s research on U.S. drug courts highlights the dual loyalty issues faced by medical professionals in this sector: courts dictate treatment protocols that run counter to best medical practice or require clinicians report to the court on patients’ progress – in violation of doctor-patient confidentiality.
Dual Loyalty | Dual Loyalty in Drug Policy
